Teradyne CEO granted RSUs and stock options

Teradyne, Inc. reported that President and CEO Gregory Stephen Smith received new equity awards.

Rhea-AI Filing Summary

Teradyne, Inc. reported that President and CEO Gregory Stephen Smith received new equity awards. On February 4, 2026, he was granted 13,380 restricted stock units, each representing one share of common stock, which vest in four equal annual installments beginning on February 4, 2027.

On the same date, he was also granted a stock option for 11,810 shares of common stock at an exercise price of $269.07 per share, vesting 25% per year over four years starting on February 4, 2027. After these grants, he beneficially owned 128,469.5729 shares of common stock directly and 11,810 stock options directly.

Insider Trade Summary

Grant/Award: 25,190 shares

Grant/Award 2 txns

Insider Smith Gregory Stephen

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	11,810	$0.00	$0.00
Grant/Award	Common Stock	13,380	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 11,810 contracts (Direct); Common Stock — 128,469.5729 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on February 4, 2027, the first anniversary of the grant.
2. F2. The option vests 25% per year over four years beginning on February 4, 2027, the first anniversary of the grant.

FAQ

What equity awards did Teradyne (TER) grant to CEO Gregory Stephen Smith?

Teradyne granted Gregory Stephen Smith 13,380 restricted stock units and a stock option for 11,810 shares of common stock. Both awards were granted on February 4, 2026 and are part of the company’s 2006 Equity and Cash Compensation Incentive Plan.

How do the new Teradyne (TER) RSUs for the CEO vest?

The 13,380 RSUs granted to Gregory Stephen Smith vest in four equal annual installments. Vesting begins on February 4, 2027, which is the first anniversary of the grant date, and continues annually over the following three years.

What are the terms of the new stock options granted to Teradyne (TER)’s CEO?

Gregory Stephen Smith received a stock option for 11,810 shares of common stock with an exercise price of $269.07 per share. The option vests 25% per year over four years, starting on February 4, 2027, and expires on February 4, 2033.

How many Teradyne (TER) shares does the CEO beneficially own after these grants?

Following the reported transactions, Gregory Stephen Smith beneficially owned 128,469.5729 shares of Teradyne common stock directly. He also held 11,810 stock options directly, reflecting the newly granted option award reported in this Form 4 filing.

Were the Teradyne (TER) CEO’s new equity awards purchased for cash?

No, the reported grants to Gregory Stephen Smith show a price of $0 for both the 13,380 RSUs and the 11,810 stock options. This indicates they were awarded as part of his compensation rather than purchased on the open market.

What is the role of Gregory Stephen Smith at Teradyne (TER)?

Gregory Stephen Smith is identified as both a Director and an Officer of Teradyne, serving as President and CEO. The Form 4 discloses equity compensation transactions related to his executive and board roles at the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Gregory Stephen

(Last) (First) (Middle)

C/O TERADYNE, INC.

600 RIVERPARK DRIVE

(Street)

NORTH READING MA 01864

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		A		13,380(1)	A	$0	128,469.5729	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$269.07	02/04/2026		A		11,810		(2)	02/04/2033	Common Stock	11,810	$0	11,810	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on February 4, 2027, the first anniversary of the grant.

2. The option vests 25% per year over four years beginning on February 4, 2027, the first anniversary of the grant.

	/s/ Ryan E. Driscoll, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.